YAP1 activation promotes epithelial–mesenchymal transition (EMT) and is associated with liver metastasis in pancreatic cancer, thereby inducing progression to a more aggressive phenotype [11,12]. Here, YAP1 is linked to familial pancreatic carcinoma.